Thermo Fisher Scientific has launched the first fully automated test for faecal calprotectin,
The test can differentiate inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis from irritable bowel syndrome (IBS) and other functional bowel disorders (BD).
The test, which can be run on Phadia instruments, offers high specificity, high sensitivity and excellent predictive values to assist with early diagnosis. A faecal calprotectin test is highly effective in discriminating IBD from IBS and in helping monitor disease activity following diagnosis.
It can also predict a relapse during clinical remission.
For more information, visit www.phadia.com.